These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30179617)

  • 1. Coffee, Caffeine Metabolism Genotype and Disease Progression in Patients with Localized Prostate Cancer Managed with Active Surveillance.
    Gregg JR; Lopez DS; Reichard C; Zheng J; Wu W; Ye Y; Chapin B; Kim J; Daniel CR; Davis J
    J Urol; 2019 Feb; 201(2):308-314. PubMed ID: 30179617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coffee Intake, Caffeine Metabolism Genotype, and Survival Among Men with Prostate Cancer.
    Gregg JR; Kim J; Logothetis C; Hanash S; Zhang X; Manyam G; Muir K; ; Giles GG; Stanford JL; Berndt SI; Kogevinas M; Brenner H; Eeles RA; ; Wei P; Daniel CR
    Eur Urol Oncol; 2023 Jun; 6(3):282-288. PubMed ID: 35995710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Association of Periprostatic Fat and Grade Group Progression in Men with Localized Prostate Cancer on Active Surveillance.
    Gregg JR; Surasi DS; Childs A; Moll N; Ward JF; Kim J; Daniel CR; Logothetis C; Bathala T; Davis JW
    J Urol; 2021 Jan; 205(1):122-128. PubMed ID: 32718204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coffee and tea consumption, genotype-based CYP1A2 and NAT2 activity and colorectal cancer risk-results from the EPIC cohort study.
    Dik VK; Bueno-de-Mesquita HB; Van Oijen MG; Siersema PD; Uiterwaal CS; Van Gils CH; Van Duijnhoven FJ; Cauchi S; Yengo L; Froguel P; Overvad K; Bech BH; Tjønneland A; Olsen A; Boutron-Ruault MC; Racine A; Fagherazzi G; Kühn T; Campa D; Boeing H; Aleksandrova K; Trichopoulou A; Peppa E; Oikonomou E; Palli D; Grioni S; Vineis P; Tumino R; Panico S; Peeters PH; Weiderpass E; Engeset D; Braaten T; Dorronsoro M; Chirlaque MD; Sánchez MJ; Barricarte A; Zamora-Ros R; Argüelles M; Jirström K; Wallström P; Nilsson LM; Ljuslinder I; Travis RC; Khaw KT; Wareham N; Freisling H; Licaj I; Jenab M; Gunter MJ; Murphy N; Romaguera-Bosch D; Riboli E
    Int J Cancer; 2014 Jul; 135(2):401-12. PubMed ID: 24318358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of coffee consumption and CYP1A2 polymorphism with risk of impaired fasting glucose in hypertensive patients.
    Palatini P; Benetti E; Mos L; Garavelli G; Mazzer A; Cozzio S; Fania C; Casiglia E
    Eur J Epidemiol; 2015 Mar; 30(3):209-17. PubMed ID: 25595320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP1A2 Genetic Variation, Coffee Intake, and Kidney Dysfunction.
    Mahdavi S; Palatini P; El-Sohemy A
    JAMA Netw Open; 2023 Jan; 6(1):e2247868. PubMed ID: 36701157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study.
    Wilson KM; Kasperzyk JL; Rider JR; Kenfield S; van Dam RM; Stampfer MJ; Giovannucci E; Mucci LA
    J Natl Cancer Inst; 2011 Jun; 103(11):876-84. PubMed ID: 21586702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coffee Consumption and Incident Tachyarrhythmias: Reported Behavior, Mendelian Randomization, and Their Interactions.
    Kim EJ; Hoffmann TJ; Nah G; Vittinghoff E; Delling F; Marcus GM
    JAMA Intern Med; 2021 Sep; 181(9):1185-1193. PubMed ID: 34279564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Habitual coffee consumption and risk of dementia in older persons: modulation by CYP1A2 polymorphism.
    Lefèvre-Arbogast S; Helmer C; Berr C; Debette S; Samieri C
    Eur J Epidemiol; 2024 Jan; 39(1):81-86. PubMed ID: 37906419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Coffee Intake With Survival in Patients With Advanced or Metastatic Colorectal Cancer.
    Mackintosh C; Yuan C; Ou FS; Zhang S; Niedzwiecki D; Chang IW; O'Neil BH; Mullen BC; Lenz HJ; Blanke CD; Venook AP; Mayer RJ; Fuchs CS; Innocenti F; Nixon AB; Goldberg RM; O'Reilly EM; Meyerhardt JA; Ng K
    JAMA Oncol; 2020 Nov; 6(11):1713-1721. PubMed ID: 32940631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-diagnostic coffee and tea consumption and risk of prostate cancer progression by smoking history.
    Langlais CS; Chan JM; Kenfield SA; Cowan JE; Graff RE; Broering JM; Carroll P; Van Blarigan EL
    Cancer Causes Control; 2021 Jun; 32(6):635-644. PubMed ID: 33837499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Coffee Drinking With Mortality by Genetic Variation in Caffeine Metabolism: Findings From the UK Biobank.
    Loftfield E; Cornelis MC; Caporaso N; Yu K; Sinha R; Freedman N
    JAMA Intern Med; 2018 Aug; 178(8):1086-1097. PubMed ID: 29971434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of a 17-Gene Genomic Prostate Score in Serial Testing of Men on Active Surveillance for Early Stage Prostate Cancer.
    Cedars BE; Washington SL; Cowan JE; Leapman M; Tenggara I; Chan JM; Cooperberg MR; Carroll PR
    J Urol; 2019 Oct; 202(4):696-701. PubMed ID: 30958742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active Surveillance for Favorable Risk Prostate Cancer in African Caribbean Men: Results of a Prospective Study.
    Meunier ME; Eyraud R; Sénéchal C; Gourtaud G; Roux V; Lanchon C; Brureau L; Blanchet P
    J Urol; 2017 May; 197(5):1229-1236. PubMed ID: 27993665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High coffee intake, but not caffeine, is associated with reduced estrogen receptor negative and postmenopausal breast cancer risk with no effect modification by CYP1A2 genotype.
    Lowcock EC; Cotterchio M; Anderson LN; Boucher BA; El-Sohemy A
    Nutr Cancer; 2013; 65(3):398-409. PubMed ID: 23530639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coffee and tea consumption in relation to prostate cancer prognosis.
    Geybels MS; Neuhouser ML; Wright JL; Stott-Miller M; Stanford JL
    Cancer Causes Control; 2013 Nov; 24(11):1947-54. PubMed ID: 23907772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating the possible causal role of coffee consumption with prostate cancer risk and progression using Mendelian randomization analysis.
    Taylor AE; Martin RM; Geybels MS; Stanford JL; Shui I; Eeles R; Easton D; Kote-Jarai Z; Amin Al Olama A; Benlloch S; Muir K; Giles GG; Wiklund F; Gronberg H; Haiman CA; Schleutker J; Nordestgaard BG; Travis RC; Neal D; Pashayan N; Khaw KT; Blot W; Thibodeau S; Maier C; Kibel AS; Cybulski C; Cannon-Albright L; Brenner H; Park J; Kaneva R; Batra J; Teixeira MR; Pandha H; ; Donovan J; Munafò MR
    Int J Cancer; 2017 Jan; 140(2):322-328. PubMed ID: 27741566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term coffee consumption, caffeine metabolism genetics, and risk of cardiovascular disease: a prospective analysis of up to 347,077 individuals and 8368 cases.
    Zhou A; Hyppönen E
    Am J Clin Nutr; 2019 Mar; 109(3):509-516. PubMed ID: 30838377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Biopsy Compliance on Outcomes for Patients on Active Surveillance for Prostate Cancer.
    Detsky JS; Ghiam AF; Mamedov A; Commisso K; Commisso A; Zhang L; Liu S; Klotz L; Loblaw A; Vesprini D
    J Urol; 2020 Nov; 204(5):934-940. PubMed ID: 32330406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Long-Term Risks of Metastases in Men on Active Surveillance for Early Stage Prostate Cancer.
    Maggi M; Cowan JE; Fasulo V; Washington SL; Lonergan PE; Sciarra A; Nguyen HG; Carroll PR
    J Urol; 2020 Dec; 204(6):1222-1228. PubMed ID: 33157570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.